Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

385 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Clinical evaluation of simultaneous confocal scanning laser ophthalmoscopy imaging combined with high-resolution, spectral-domain optical coherence tomography.
Helb HM, Charbel Issa P, Fleckenstein M, Schmitz-Valckenberg S, Scholl HP, Meyer CH, Eter N, Holz FG. Helb HM, et al. Among authors: meyer ch. Acta Ophthalmol. 2010 Dec;88(8):842-9. doi: 10.1111/j.1755-3768.2009.01602.x. Acta Ophthalmol. 2010. PMID: 19706019
Combined intravitreal anti-vascular endothelial growth factor (Avastin) and photodynamic therapy to treat retinal juxtapapillary capillary haemangioma.
Mennel S, Meyer CH, Callizo J. Mennel S, et al. Among authors: meyer ch. Acta Ophthalmol. 2010 Aug;88(5):610-3. doi: 10.1111/j.1755-3768.2008.01449.x. Epub 2009 Feb 12. Acta Ophthalmol. 2010. PMID: 19222401
Predictive factors for functional improvement after intravitreal bevacizumab therapy for macular edema due to branch retinal vein occlusion.
Jaissle GB, Szurman P, Feltgen N, Spitzer B, Pielen A, Rehak M, Spital G, Heimann H, Meyer CH; Retinal Vein Occlusion Study Group. Jaissle GB, et al. Among authors: meyer ch. Graefes Arch Clin Exp Ophthalmol. 2011 Feb;249(2):183-92. doi: 10.1007/s00417-010-1470-2. Epub 2010 Aug 18. Graefes Arch Clin Exp Ophthalmol. 2011. PMID: 21337042 Free PMC article. Clinical Trial.
Incidence of rhegmatogenous retinal detachments after intravitreal antivascular endothelial factor injections.
Meyer CH, Michels S, Rodrigues EB, Hager A, Mennel S, Schmidt JC, Helb HM, Farah ME. Meyer CH, et al. Acta Ophthalmol. 2011 Feb;89(1):70-5. doi: 10.1111/j.1755-3768.2010.02064.x. Epub 2010 Dec 22. Acta Ophthalmol. 2011. PMID: 21176118 Clinical Trial.
Time between symptom onset and assessment in age-related macular degeneration with subfoveal choroidal neovascularization.
Schalnus R, Meyer CH, Kuhli-Hattenbach C, Lüchtenberg M. Schalnus R, et al. Among authors: meyer ch. Ophthalmologica. 2010;224(3):176-82. doi: 10.1159/000239236. Epub 2009 Sep 17. Ophthalmologica. 2010. PMID: 19776657 Clinical Trial.
Retinal pigment epithelial tears after intravitreal bevacizumab injection for neovascular age-related macular degeneration.
Chan CK, Meyer CH, Gross JG, Abraham P, Nuthi AS, Kokame GT, Lin SG, Rauser ME, Kaiser PK. Chan CK, et al. Among authors: meyer ch. Retina. 2007 Jun;27(5):541-51. doi: 10.1097/IAE.0b013e3180cc2612. Retina. 2007. PMID: 17558314 Clinical Trial.
Macular hole formation in the presence of a pigment epithelial detachment after three consecutive intravitreal antivascular endothelial growth factor injections.
Clemens CR, Holz FG, Meyer CH. Clemens CR, et al. Among authors: meyer ch. J Ocul Pharmacol Ther. 2010 Jun;26(3):297-9. doi: 10.1089/jop.2009.0140. J Ocul Pharmacol Ther. 2010. PMID: 20565318
385 results
Jump to page
Feedback